Gordian Capital (Singapore)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-350
Closed -$2.83K 169
2025
Q1
$2.83K Hold
350
﹤0.01% 130
2024
Q4
$3.18K Hold
350
﹤0.01% 125
2024
Q3
$3.21K Hold
350
﹤0.01% 122
2024
Q2
$3.42K Hold
350
﹤0.01% 116
2024
Q1
$5.29K Buy
+350
New +$6.35K ﹤0.01% 68

Other funds holding TDOC

Gordian Capital (Singapore)'s TDOC Position: Q2 2025 in Review

Gordian Capital (Singapore) sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 350 shares — an estimated $2.83K sold.

Gordian Capital (Singapore) first reported a position in TDOC in Q1 2024 and held it in 5 quarters. The position peaked at $5.29K in Q1 2024. 359 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • Gordian Capital (Singapore) reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • Gordian Capital (Singapore) sold 350 Teladoc Health shares in Q2 2025, an estimated $2.83K.
  • Gordian Capital (Singapore) first reported a position in Teladoc Health in Q1 2024 and held it in 5 quarters.
  • Gordian Capital (Singapore)'s Teladoc Health position peaked at $5.29K in Q1 2024.
  • 359 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on Gordian Capital (Singapore)'s 13F filing for Q2 2025, filed 14 Aug 2025.